Claudins in kidney health and disease

Chor ho Jo; Sua Kim; Gheun-Ho Kim

doi:10.23876/j.krcp.21.279

Kidney Res Clin Pract > Volume 41(3); 2022 > Article

Jo, Kim, and Kim: Claudins in kidney health and disease

Review Article

Kidney Research and Clinical Practice 2022;41(3):275-287.

Published online: March 15, 2022

DOI: https://doi.org/10.23876/j.krcp.21.279

Claudins in kidney health and disease

Chor ho Jo¹

, Sua Kim¹

, Gheun-Ho Kim^1,²

¹Hanyang Biomedical Research Institute, Hanyang University College of Medicine, Seoul, Republic of Korea

²Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Republic of Korea

Correspondence: Gheun-Ho Kim Department of Internal Medicine, Hanyang University College of Medicine, 222-1 Wangsimni-ro, Seongdong-gu, Seoul 04763, Republic of Korea. E-mail: kimgh@hanyang.ac.kr

This paper is based on a talk given by Gheun-Ho Kim at the 41st Annual Meeting of the Korean Society of Nephrology (September 4, 2021) in Seoul, Korea.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial and No Derivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/) which permits unrestricted non-commercial use, distribution of the material without any modifications, and reproduction in any medium, provided the original works properly cited.

Abstract

Claudins are strategically located to exert their physiologic actions along with the nephron segments from the glomerulus. Claudin-1 is normally located in the Bowman’s capsule, but its overexpression can reach the podocytes and lead to albuminuria. In the proximal tubule (PT), claudin-2 forms paracellular channels selective for water, Na⁺, K⁺, and Ca²⁺. Claudin-2 gene mutations are associated with hypercalciuria and kidney stones. Claudin-10 has two splice variants, -10a and -10b; Claudin-10a acts as an anion-selective channel in the PT, and claudin-10b functions as a cation-selective pore in the thick ascending limb (TAL). Claudin-16 and claudin-19 mediate paracellular transport of Na⁺, Ca²⁺, and Mg²⁺ in the TAL, where the expression of claudin-3/16/19 and claudin-10b are mutually exclusive. The claudin-16 or -19 mutation causes familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Claudin-14 polymorphisms have been linked to increased risk of hypercalciuria. Claudin-10b mutations produce HELIX syndrome, which encompasses hypohidrosis, electrolyte imbalance, lacrimal gland dysfunction, ichthyosis, and xerostomia. Hypercalciuria and magnesuria in metabolic acidosis are related to downregulation of PT and TAL claudins. In the TAL, stimulation of calcium-sensing receptors upregulates claudin-14 and negatively acts on the claudin-16/19 complex. Claudin-3 acts as a general barrier to ions in the collecting duct. If this barrier is disturbed, urine acidification might be impaired. Claudin-7 forms a nonselective paracellular channel facilitating Cl^– and Na⁺ reabsorption in the collecting ducts. Claudin-4 and -8 serve as anion channels and mediate paracellular Cl^– transport; their upregulation may contribute to pseudohypoaldosteronism II and salt-sensitive hypertension.

Keywords: Claudinopathy, Collecting duct, Electrolytes, Glomerulus, Proximal tubule, Thick ascending limb

Introduction

Urinary excretion of solutes, ions, and water is determined by the tubular transport removed from the glomerular filtrates. Renal tubular transport (either via reabsorption or secretion) occurs through both transcellular and paracellular pathways. Traditionally, renal regulatory function for fluid and electrolyte balance is exerted by changes in transcellular transport across the renal tubular epithelial cells. However, the regulatory roles of paracellular transport in the kidney remain incompletely known.

The junctional complexes located in the paracellular route comprise tight junctions (TJs), adherence junctions, and desmosomes [1]. The TJ is composed of three components of transmembrane bridging proteins: claudin, occludin, and junctional adhesion molecules. The C-terminus of each has a PDZ binding domain linked to scaffold zonula occludens (ZO) proteins. The ZO proteins can bind directly to cytoskeleton actin filaments [2]. In glomerular epithelial cells, the glomerular slit diaphragm has specialized transmembrane bridging proteins (nephrin and podocin) between podocyte foot processes [3].

Furuse et al. [4] identified occludin as the first component of TJs, and its abundance is related to the degree of sealing of the epithelia [5]. However, occludin knockout mice displayed well-developed TJs [6]. They also found another integral component of TJs that might have a critical role in paracellular transport. Using the same liver fraction as employed to identify occludin, a single 22-kD band was discovered by stepwise sucrose density gradient centrifugation. Peptide sequencing revealed two proteins in this band that were subsequently named claudin 1 and 2. The name “claudin” is derived from the Latin word “claudere,” which means to close [7].

Claudins can characterize TJs because they polymerize in a linear fashion and form TJ strands with paracellular barriers or pore functions [8]. The claudin family has 27 members [9], many of which are located in the mammalian nephron [10]. Claudins contain from 21- to 28-kDa proteins and consist of four transmembrane domains, two extracellular loops (ECLs), amino- and carboxy-terminal cytoplasmic domains, and a short cytoplasmic turn (Fig. 1). The paracellular ion selectivity is determined by the charged amino acid residues located in the ECL1. The ECL2 has binding sites for claudin interactions [11]. Table 1 summarizes different claudins according to ion permeability and selectivity based on in vitro studies using cultured cell lines and ex vivo studies using knockout mice [12–42]. The results can be discrepant depending on the properties of the tested cells and animals.

Glomerular claudins

Claudins are located along with nephron segments from the glomerulus, where they exert their physiologic actions. Claudin-1 is mainly located in Bowman’s capsule or parietal epithelial cells [43]. Gong et al. [43] showed that claudin-1 overexpression was associated with overt albuminuria. In transgenic mice with claudin-1 overexpression, claudin-1 protein labeling extended to the glomerular tuft, localizing in the podocytes. Claudin-1 messenger RNA (mRNA) and protein levels also increased in the glomeruli of the representative animal model of nephrotic syndrome, puromycin aminonucleoside nephrosis (PAN). As nephrin expression declined, claudin-1 expression reached the glomerular tuft, colocalizing with nephrin in PAN glomeruli. Claudin-1 might interact with nephrin and podocin, disrupting the endogenous nephrin and podocin interactions that hold the slit diaphragm in place [43]. Thus, proteinuria can result from claudin-1 overexpression.

However, it remains unclear whether upregulation of claudin-1 is the cause of proteinuria or just a mediator of podocyte injury. In normal conditions, a high concentration of nicotinamide mononucleotide (NMN) leads to epigenetic silencing of the promoter of claudin-1 by Sirt1 in podocytes [44]. Hasegawa et al. [45] reported that, in diabetic mice, proximal tubule Sirt1 expression decreased and was followed by a decrease in NMN concentration. In the absence of NMN, the claudin-1 promoter was no longer silenced, leading to increased claudin-1 expression in podocytes and causing foot process effacement and albuminuria. Thus, proximal tubule Sirt 1 exerts regulatory action on claudin-1, but this scenario was not valid in nondiabetic animals, such as 5/6 nephrectomized mice.

Claudin-5 and claudin-6 are expressed in glomerular podocytes. When claudin mRNA levels were quantified in isolated rat glomeruli, claudin-5 expression was most abundant [46]. Its podocyte localization was demonstrated by immunoelectron microscopy and might be altered in PAN rats [46].

According to Zhao et al. [47], claudin-6 is localized in the TJs of rat podocytes. Claudin-6 was expressed in most of the tubules and glomeruli in neonates, but the expression in tubules dwindled in adults and was well-preserved in the glomeruli during development. Immunoelectron microscopy revealed that claudin-6 was distributed along the glomerular capillary wall and colocalized with ZO-1, and that its level of expression was not significantly altered in PAN rats [47].

Proximal tubule claudins

The major proximal tubule claudins are claudin-2 and claudin-10a. Claudin-2 forms paracellular channels selective for small cations such as Na⁺, K⁺, and Ca²⁺ and is also permeable to H₂O so that 20% to 25% of proximal water absorption can occur paracellularly. It appears that cations and water travel through the same pore, where the amino acid residues in the ECL1 of claudin-2 line the narrowest part [48].

The function of claudin-2 can be inferred from knockout animals. Net transepithelial reabsorption of Na⁺, Cl^–, and H₂O was reduced from isolated perfused S2 segments of the proximal tubules in claudin-2 knockout mice [49]. These changes were associated with an increase in paracellular electrical resistance but no changes in the apical and basolateral membrane resistance that represents transcellular electrical resistance.

The transepithelial resistance (TER) is an indicator of permeability and varies inversely with paracellular permeability; it progressively increases from the proximal tubule or leaky epithelia to the collecting duct or tight epithelia. This finding is relevant because approximately two-thirds of the glomerular filtered fluid is reabsorbed in the proximal tubule, and fine tuning of tubular transport occurs in the distal nephron [50]. Previous claudin-2 knockdown or overexpression studies were mostly from Madin-Darby canine kidney (MDCK) or tight epithelial cells. We tested the effects of TJ protein depletion in truly leaky human kidney-2 (HK-2) cells. Fig. 2 shows TER and immunoblot results from HK-2 cells transfected with small-interfering RNAs against claudin-2, occludin, and ZO-1. With claudin-2 knockdown, an increase in occludin was associated with and might have led to a decrease in TER. When occludin was knocked down, claudin-2 was suppressed, leading to increased TER. Similarly, TER was increased by ZO-1 knockdown in association with a decrease in claudin-2 [51]. We concluded that integration of claudin-2, occludin and ZO-1 is necessary for maintaining the function of the proximal tubular epithelium.

Claudin-10 has two splice variants; -10a and -10b, respectively located in the proximal tubule and the thick ascending limb (TAL). In the proximal tubule, claudin-10a acts as an anion-selective channel (e.g., chloride absorption), whereas claudin-2 functions as a cation-selective pore [52,53]. Further independent roles of claudin-10a in the kidney remain to be determined.

The paracellular sodium transport mediated by claudin-2 contributes to energy efficiency in the kidney. Pei et al. [54] showed that claudin-2 knockout mice had larger renal oxygen consumption amounts for tubular sodium transport and a consequently lower energy efficiency. In addition, medullary hypoxia was suggested in claudin-2 knockout mice as they demonstrated remarkable furosemide-induced improvement of oxygen tension in the outer medulla. In brief, proximal tubule and TAL sodium transport are interconnected and share their load of transport. If the paracellular sodium transport is blocked in the proximal tubule, the transport load is shifted to the TAL, where Na-K-Cl cotransporter 2 (NKCC2) hyperactivity can enhance energy consumption [55].

Claudin-2 also has pathophysiological significance in calcium metabolism. Claudin-2 knockout mice demonstrate hypercalciuria due to decreased proximal tubular calcium reabsorption, which leads to papillary nephrocalcinosis and kidney stones. These results can be accentuated by decreased colonic calcium secretion or increased intestinal calcium absorption. Two large population-based studies have shown that common polymorphisms in the claudin-2 gene were associated with increased risk of kidney stones. Finally, a family case study was described in which males with a rare missense mutation in claudin-2 had marked hypercalciuria and kidney stone disease [56].

Metabolic acidosis can be associated with increased urinary calcium excretion. The protein level of claudin-2 decreased in rats with chronic metabolic acidosis and in MDCK II and HK-2 cells in response to an acidic pH [57]. The authors interpreted these results as an attempt to compensate for the chronic state of metabolic acidosis because the downregulation of claudin-2 might be associated with an increase in Na⁺/H⁺ exchanger 3 (NHE3) activity in the proximal tubule. However, Pei et al. [54] reported that the total and phosphorylated NHE3 abundance decreased by 23% and 27%, respectively, in claudin-2 knockout kidneys.

Thick ascending limb claudins

The major TAL claudins are claudin-3, -10b, -14, -16, and -19. They mediate paracellular transport of cations such as Na⁺, Ca²⁺, and Mg²⁺. The transcellular transport system is composed of apical NKCC2 and renal outer medullary potassium channels (ROMK) and of basolateral Na⁺/K⁺-ATPase and ClC-Kb chloride channels. In the cortex and outer stripe of the outer medulla (OSOM), the lumen-positive voltage produced by apical K⁺ recycling drives paracellular reabsorption of divalent cations via the claudin-16/19 complex. Here, paracellular Na⁺ transport can act in reverse and add to the lumen-positive transepithelial voltage. In the inner stripe of the outer medulla, however, Na⁺ is paracellularly reabsorbed through claudin-10b to contribute to medullary hypertonicity [58,59].

In Fig. 3, immunofluorescence microscopy shows that localization of claudin-10 does not overlap with that of claudin-16. However, claudin-16 and -19 are colocalized [60]. Similarly, claudin-3 and claudin-19 can be colocalized with each other but not with claudin-10. This characteristic claudin expression in the TAL was reported as a mosaic pattern. According to Milatz et al. [13], claudin-3 and claudin-19 were expressed in the intracellular compartment of all cortex/OSOM TAL cells. However, claudin-16 was strictly localized to the TJs. In brief, the expression of claudin-3/16/19 and claudin-10b are mutually exclusive in the TAL, and the two arrangements respectively mediate divalent and monovalent cation transport [61].

Next to the proximal tubule, the TAL is the major site of paracellular calcium transport in the kidney [61]. Divalent cations Ca²⁺ and Mg²⁺ are reabsorbed through the claudin-16/19 complex, and claudin-14 negatively regulates claudin-16 and -19 via direct interaction. During upstream signaling, microRNAs (miR-9 and miR-374) regulate claudin-14 mRNA stability and suppress translational efficacy. Gene transcription of microRNAs is regulated by the transcriptional factor nuclear factor of activated T cells (NFAT) and also via deacetylation of nearby histone molecules [62]. Consequently, claudin-14 is upregulated by stimulation of the calcium-sensing receptor (CaSR) [63].

The downregulation of claudin-2 in metabolic acidosis was described above, and we further investigated the role of TAL claudins in metabolic acidosis-induced hypercalciuria and hypermagnesiuria [64]. Fig. 4 shows that, in acid-loaded rats, both claudin-16 and claudin-19 expression decreased compared with those in controls. However, claudin-14 and CaSR expression increased in acid-loaded rats. All these changes were reversed by coadministration of the CaSR antagonist NPS-2143 and were confirmed using immunofluorescence microscopy. Hypercalciuria and hypermagnesiuria in acid-loaded rats also were significantly ameliorated by NPS-2143 coadministration. Thus, claudin-16 and claudin-19 are downregulated by metabolic acidosis via the CaSR.

Genetic defects in TAL claudins are directly linked to human diseases. The calcium- and magnesium-wasting disorder caused by either a claudin-16 or -19 mutation is called familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC). The claudin-19 disorder is accompanied by severe ocular defects and is classified as type 2 FHHNC. The phenotype of the claudin-14 mutation is characterized by deafness without renal manifestations. Claudin-10b mutations produce HELIX syndrome, which encompasses hypohidrosis, electrolyte imbalance, lacrimal gland dysfunction, ichthyosis, and xerostomia and is suggestive of abnormalities in renal ion transport, ectodermal gland homeostasis, and epidermal integrity [58].

It is interesting that claudin-14 channelopathy has no renal manifestations. However, claudin-14 knockout mice have demonstrated reduced fractional excretion of calcium and magnesium in response to high dietary calcium intake [65]. Consistent with this, claudin-14 gene polymorphisms have been associated with differences in urinary calcium excretion, whereas no associations were found with claudin-16 and -19 polymorphisms [66].

The claudin-10 mutation HELIX syndrome is characterized by lack of sweat, saliva, and tears, and it has an autosomal recessive inheritance pattern. Renal manifestations include hypokalemia, hypocalciuria, and hypermagnesemia, as shown in a case series [67]. The data from claudin-10 knockout mice can explain this renal phenotype. Conditioned knockout mice deficient in claudin-10b were generated, and the absence of claudin-10b decreased Na⁺ permeability and increased Mg²⁺ and Ca²⁺ permeability in isolated perfused TALs [14]. Sodium wasting might be linked to an increase in fractional excretion of potassium, and increased magnesium and calcium reabsorption could lead to hypermagnesemia and hypocalciuria in claudin-10b knockout mice. A different feature of claudin-10b knockout mice from HELIX syndrome in humans was the presence of nephrocalcinosis. Interestingly, upregulation of both claudin-16 and claudin-19 was induced in claudin-10b knockout mice and can explain these results [14].

Collecting duct claudins

Claudin-3, -4, -7, and -8 are mainly located in the collecting duct. Claudin-3 acts as a general barrier for ions, and it can promote urinary acidification due to blockage of H⁺ back-leak [68]. The sealing effect of claudin-3 against ions of either charge and uncharged solutes was demonstrated by its overexpression in MDCK II cells, which induced a marked increase in paracellular resistance and decreases in permeability of sodium, chloride, and larger molecules, such as 4-kDa dextran [41].

In the collecting duct, a transepithelial voltage of −25 mV with respect to the basolateral side drives Cl⁻ transport through the paracellular channel, which is made up of claudin-4, -7, or -8 [10]. Thus, claudin-4 and -8 serve as selective anion channels, mediating a “chloride shunt,” which is coupled with transcellular Na⁺ reabsorption via the epithelial Na⁺ channel (ENaC). They may also act as Na⁺ barriers [68]. Collecting duct-specific knockout of either claudin-4 or claudin-8 causes hypotension, hypochloremia, metabolic alkalosis, and renal salt wasting [69,70].

Claudin-7 can form a nonselective paracellular channel that facilitates Cl^– and Na⁺ reabsorption in the collecting duct [71]. Claudin-7 knockout mice die shortly after birth due to severe renal salt wasting and dehydration, which is suggestive of the essential roles of claudin-7 and the collecting duct paracellular NaCl transport in maintaining fluid balance [72].

We postulated that claudin-4 or -8 upregulation contributes to salt-sensitive hypertension, and this hypothesis was tested in Dahl salt rats (Fig. 5). Compared with Dahl salt-resistant rats, Dahl salt-sensitive rats had higher blood pressure and reduced sodium excretion. In the kidney, claudin-4 protein and mRNA levels increased, and occludin protein and mRNA decreased [73]. These results might be responsible for salt retention or impaired pressure natriuresis because claudin-4 is a chloride pore, and occludin is a nonspecific or sodium barrier located along the tubule.

Hou et al. [23] reported that claudin-4 requires claudin-8 for TJ localization. Claudin-4 protein expression was suppressed by claudin-8 gene knockdown in polarized M-1 cells, whereas claudin-3 and -7 expression were not affected. In the absence of the claudin-8 gene, claudin-4 expression was confined to the endoplasmic reticulum and the Golgi apparatus and was not observed in the apical cell membrane where TJs are located.

Another regulatory factor of claudin-4 is channel-activating protease-1 (CAP1). When the cells were treated with CAP1, the expression of claudin-4 at the TJs was reduced, whereas ZO-1 expression was not affected. CAP1 decreased the cell membrane expression levels of claudin-4 and reduced paracellular Cl^– permeability by disrupting claudin-4 trans-interaction [69].

In the collecting duct principal cells, aldosterone stimulates transcellular Na⁺ reabsorption and K⁺ secretion via ENaC and ROMK, respectively. In addition, aldosterone can affect paracellular Cl^– absorption by regulating claudins [68]. Aldosterone activates CAP1, which inhibits claudin-4, as previously mentioned. Aldosterone also induces phosphorylation of with-no-lysine kinase-4 (WNK4), and activated WNK4 phosphorylates claudin-4 on threonine residues to promote the chloride shunt [68]. Deletion of the claudin-7 gene in collecting duct cells induced upregulation of WNK4 and ENaC [71].

We previously tested this theme in cyclosporine-treated rats because hyperchloremic metabolic acidosis is often encountered in patients using cyclosporine [74]. In the kidney, the protein expression of the Na-Cl cotransporter (NCC) was decreased by cyclosporine treatment, which suggested a decrease in transcellular chloride transport. Instead, WNK4 increased in cyclosporine-treated rat kidneys. WNK4 upregulation was confirmed by in vitro cell culture studies and in vivo immunohistochemistry [75]. However, claudin-4 phosphorylation was not demonstrated in this study.

Transcellular and paracellular transport are interlinked in the collecting duct as well. Normally, transcellular sodium absorption occurs via ENaC, and paracellular Na⁺ back-leak is prevented by claudin-8 barrier. When the ENaC is hyperactive, the claudin-8 barrier is strengthened to block Na⁺ back-leak. In contrast, when the ENaC is inactivated, the claudin-8 barrier is weakened to promote Na⁺ back-leak [76]. Thus, claudin-8 combines with ENaC to enable unidirectional sodium transport across the collecting duct.

Claudinopathy

As the regulatory function and pathophysiology of claudins continue to be explored in the kidney, diseases associated with defective claudins have been termed “claudinopathies” [77]. Fig. 6 illustrates different claudinopathies along the nephron that have been described in previous experimental and clinical studies. Claudin-1 overexpression in the glomerular podocytes might have a role in albuminuria [43]. Claudin-2 and claudin-14 polymorphisms are associated with altered urine calcium excretion [56,66], which is suggestive of a role in idiopathic hypercalciuria. Hypercalciuria in metabolic acidosis is related to downregulation of both proximal tubule and TAL claudins [57,64]. Claudin-16 and claudin-19 mutations lead to FHHNC type 1 and type 2, respectively. Claudin-10b mutations can cause HELIX syndrome, which presents with hypokalemia, hypermagnesemia, and hypocalciuria [58,67]. Upregulation of claudin-4 and/or -8 may play a role in the chloride shunt, producing pseudohypoaldosteronism II and salt-sensitive hypertension [69,70].

Conclusion

Recent data from claudin studies have indicated that the paracellular pathways along the nephron are actively involved in renal physiology and pathophysiology. As the ion permeability and selectivity of different claudins continue to be defined, further studies will be required to show the regulatory and pathogenic roles of claudins in various electrolyte disorders. Understanding the interactions between paracellular and transcellular transport pathways will provide deeper insight into integrative renal physiology.

Notes

Conflict of interest

All authors have no conflicts of interest to declare.

Funding

The work was supported by grants from the National Research Foundation of Korea (NRF-2018R1D1A1A02047590 and 2020R1I1A1A01074620).

Authors’ contributions

Conceptualization: GHK

Formal analysis, Investigation: CJ, GHK

Experiments, Visualization: CJ, SK

Writing–Original Draft: GHK

Writing–Review & Editing: CJ, GHK

All authors read and approved the final manuscript.

Figure 1.

Claudin topology.

Claudins consist of four transmembrane domains (TMDs), two extracellular loops (ECLs), amino- and carboxy-terminal cytoplasmic domains, and a short cytoplasmic turn. The paracellular ion selectivity is determined by the charged amino acid residues located in ECL1. ECL2 contains binding sites for claudin interactions.

Adapted from the article of Bhat et al. [11], according to the Creative Commons License.

Figure 2.

The effects of claudin-2, occludin, and ZO-1 gene knockdown on TER and expression of other tight junction proteins in HK-2 cells.

HK-2 cells were transfected with small-interfering RNAs (siRNA) against claudin-2, occludin, and ZO-1. (A) TER was significantly decreased by claudin-2 siRNA transfection but significantly increased by siRNA transfection against occludin or ZO-1. Data are mean ± standard deviation of three independent experiments. ^*p < 0.05 vs. vehicle by Student t test for unpaired data. (B) Claudin-2 deficiency elevated occludin expression, occludin deficiency reduced claudin-2 expression, and ZO-1 deficiency also reduced claudin-2 expression. Adapted from the article of Kim and Kim [51], according to the Creative Commons License.

HK-2, human kidney 2; TER, transepithelial electrical resistance; ZO-1, zonula occludens-1.

Figure 3.

The distinct expression of claudin-10, claudin-16, and claudin-19 in the mouse cortical thick ascending limb.

(A) Immunofluorescence microscopy reveals that localization of claudin-10 (Cldn 10, green) does not overlap with that of claudin-16 (Cldn 16, red). (B) Claudin-16 (Cldn 16, red) and claudin-19 (Cldn 19, green) are colocalized in the mouse cortical thick ascending limb. Bar = 20 μm. Adapted from the article of Prot-Bertoye and Houillier [60], according to the Creative Commons License.

Figure 4.

Alteration of the thick ascending limb claudins in metabolic acidosis.

(A) Immunoblots were performed from rat kidneys after a 7-day experiment. Each lane was loaded with a protein sample from a different rat and reacted with a specific antibody. (B) Densitometric analysis of the immunoblot bands reveals decreased claudin-16 and claudin-19 and increased claudin-14 and calcium-sensing receptor (CaSR) protein in NH₄Cl-loaded rats. These changes were reversed by coadministration of the CaSR antagonist NPS-2143. (C) Immunofluorescence microscopy shows the altered expression of claudin-16, claudin-19, claudin-14, and CaSR in the thick ascending limb from each group of animals (magnification, ×400). ^*p < 0.05 vs. control; ^#p < 0.05 vs. cinacalcet; ^§p < 0.05 vs. NH₄Cl by Mann-Whitney U test. Adapted from the article of Oh et al. [64] with original copyright holder’s permission.

Figure 5.

Impaired pressure natriuresis and altered tight junction proteins in Dahl salt-sensitive rats.

The rats were fed an 8% NaCl diet for 4 weeks. (A) Compared with Dahl salt-resistant rats (SR), Dahl salt-sensitive rats (SS) had higher blood pressure and lower urinary NaCl excretion. (B) Quantitative polymerase chain reaction analysis from whole kidneys shows decreased occludin messenger RNA (mRNA) and increased zonula occludens-1 (ZO-1) and claudin-4 mRNA in SS rats compared with SRs. Data are mean ± standard error. (C) Immunoblot results also reveal that occludin decreased and claudin-4 protein increased in SS compared with SRs. ^*p < 0.05 by the Mann-Whitney U test. Adapted from the article of Jo et al. [73], according to the Creative Commons License.

BW, body weight; SBP, systolic blood pressure.

Figure 6.

The pathophysiology of claudins in the mammalian kidney.

Different phenotypes or claudinopathies can be produced by dysregulation of claudins along the nephron.

FHHNC, familial hypomagnesemia with hypercalciuria and nephrocalcinosis; HELIX presents as hypohidrosis, electrolyte imbalance, lacrimal gland dysfunction, ichthyosis, and xerostomia.

▲, overexpression; ▽, knockdown; ◈, polymorphism.

Table 1.

Ion permeability and selectivity of claudins

Ion permeability	Claudins (selectivity)	Tested cells or mice	Reference
Cation pore	Claudin-2 (Na⁺, K⁺, Ca²⁺)	MDCK I, MDCK II	[12]
	Claudin-10b (Na⁺)	HEK-293	[13]
		Claudin-10 KO	[14]
		MCDK-C7, MDCK II, LLC-PK1	[15,16]
	Claudin-12 (Ca²⁺)	Claudin-12 KO	[17]
	Claudin-16 (Na⁺, Ca²⁺, Mg²⁺)	MDCK II, LLC-PK1	[18]
		MDCK-C7	[19]
		MDCK	[20,21]
		Claudin-16 KD	[22]
Anion pore	Claudin-4 (Cl^–)	M-1, mIMCD3	[23]
	Claudin-4 (Cl^–)	MDCK II, LLC-PK1	[24,25]
	Claudin-7 (Cl^–)	MDCK II, LLC-PK1	[24]
	Claudin-8 (Cl^–)	M-1, mIMCD3	[23]
	Claudin-8 (Cl^–)	MDCK II, LLC-PK1	[24]
	Claudin-10a (Cl^–)	MDCK-C7, MDCK II, LLC-PK1	[15,16]
	Claudin-17 (Cl^–)	MDCK-C7, LLC-PK1	[26,27]
Cation barrier	Claudin-5 (Na⁺, K⁺)	MDCK II	[28]
	Claudin-8 (Na⁺, K⁺, H⁺)	MDCK II	[29,30]
	Claudin-14 (Na⁺, Ca⁺)	OK, MDCK, MDCK II	[31,32]
	Claudin-14 (Na⁺, Ca⁺)	FVB/N mice	[32]
	Claudin-18 (Na⁺, H⁺)	MDCK II	[33]
	Claudin-19 (Ca²⁺, Mg²⁺)	MDCK II	[34]
Anion barrier	Claudin-6 (Cl^–)	MDCK II	[35]
	Claudin-7 (Cl^–)	LLC-PK1	[36,37]
	Claudin-9 (Cl^–)	MDCK II	[35]
	Claudin-19 (Cl^–)	LLC-PK1, claudin-19 KD	[22,38]
Nonselective barrier	Claudin-1	MDCK	[39,40]
Nonselective barrier	Claudin-3	MDCK II	[41]
Water pore	Claudin-2	MDCK-C7	[42]

FVB, Friend leukemia virus B; HEK-293, human embryonic kidney 293; KD, knockdown; KO, knockout; LLC-PK1, Lilly Laboratories Culture-Porcine Kidney 1; MDCK, Madin-Darby canine kidney; MDCK-C7, MDCK-clone 7; mIMCD3, mouse inner medullary collecting duct cell line 3; M-1, mouse kidney cortical collecting duct cell line 1; OK, opossum kidney.

References

1. Muto S, Furuse M, Kusano E. Claudins and renal salt transport. Clin Exp Nephrol 2012;16:61–67.

2. Li J, Ananthapanyasut W, Yu AS. Claudins in renal physiology and disease. Pediatr Nephrol 2011;26:2133–2142.

3. Lee DB, Huang E, Ward HJ. Tight junction biology and kidney dysfunction. Am J Physiol Renal Physiol 2006;290:F20–F34.

4. Furuse M, Hirase T, Itoh M, et al. Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 1993;123(6 Pt 2):1777–1788.

5. Gonzalez-Mariscal L, Namorado MC, Martin D, et al. Tight junction proteins ZO-1, ZO-2, and occludin along isolated renal tubules. Kidney Int 2000;57:2386–2402.

6. Saitou M, Furuse M, Sasaki H, et al. Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell 2000;11:4131–4142.

7. Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 1998;141:1539–1550.

8. Tsukita S, Tanaka H, Tamura A. The claudins: from tight junctions to biological systems. Trends Biochem Sci 2019;44:141–152.

9. Tamura A, Tsukita S. Paracellular barrier and channel functions of TJ claudins in organizing biological systems: advances in the field of barriology revealed in knockout mice. Semin Cell Dev Biol 2014;36:177–185.

10. Hou J, Rajagopal M, Yu AS. Claudins and the kidney. Annu Rev Physiol 2013;75:479–501.

11. Bhat AA, Syed N, Therachiyil L, et al. Claudin-1, a double-edged sword in cancer. Int J Mol Sci 2020;21:569.

12. Furuse M, Furuse K, Sasaki H, Tsukita S. Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J Cell Biol 2001;153:263–272.

13. Milatz S, Himmerkus N, Wulfmeyer VC, et al. Mosaic expression of claudins in thick ascending limbs of Henle results in spatial separation of paracellular Na+ and Mg2+ transport. Proc Natl Acad Sci U S A 2017;114:E219–E227.

14. Breiderhoff T, Himmerkus N, Stuiver M, et al. Deletion of claudin-10 (Cldn10) in the thick ascending limb impairs paracellular sodium permeability and leads to hypermagnesemia and nephrocalcinosis. Proc Natl Acad Sci U S A 2012;109:14241–14246.

15. Van Itallie CM, Rogan S, Yu A, Vidal LS, Holmes J, Anderson JM. Two splice variants of claudin-10 in the kidney create paracellular pores with different ion selectivities. Am J Physiol Renal Physiol 2006;291:F1288–F1299.

16. Günzel D, Stuiver M, Kausalya PJ, et al. Claudin-10 exists in six alternatively spliced isoforms that exhibit distinct localization and function. J Cell Sci 2009;122(Pt 10):1507–1517.

17. Plain A, Pan W, O’Neill D, et al. Claudin-12 knockout mice demonstrate reduced proximal tubule calcium permeability. Int J Mol Sci 2020;21:2074.

18. Hou J, Paul DL, Goodenough DA. Paracellin-1 and the modulation of ion selectivity of tight junctions. J Cell Sci 2005;118(Pt 21):5109–5118.

19. Kausalya PJ, Amasheh S, Günzel D, et al. Disease-associated mutations affect intracellular traffic and paracellular Mg2+ transport function of Claudin-16. J Clin Invest 2006;116:878–891.

20. Ikari A, Hirai N, Shiroma M, et al. Association of paracellin-1 with ZO-1 augments the reabsorption of divalent cations in renal epithelial cells. J Biol Chem 2004;279:54826–5432.

21. Ikari A, Matsumoto S, Harada H, et al. Phosphorylation of paracellin-1 at Ser217 by protein kinase A is essential for localization in tight junctions. J Cell Sci 2006;119(Pt 9):1781–1789.

22. Hou J, Renigunta A, Gomes AS, et al. Claudin-16 and claudin-19 interaction is required for their assembly into tight junctions and for renal reabsorption of magnesium. Proc Natl Acad Sci U S A 2009;106:15350–15355.

23. Hou J, Renigunta A, Yang J, Waldegger S. Claudin-4 forms paracellular chloride channel in the kidney and requires claudin-8 for tight junction localization. Proc Natl Acad Sci U S A 2010;107:18010–18015.

24. Hou J, Gomes AS, Paul DL, Goodenough DA. Study of claudin function by RNA interference. J Biol Chem 2006;281:36117–36123.

25. Van Itallie C, Rahner C, Anderson JM. Regulated expression of claudin-4 decreases paracellular conductance through a selective decrease in sodium permeability. J Clin Invest 2001;107:1319–1327.

26. Krug SM, Günzel D, Conrad MP, et al. Claudin-17 forms tight junction channels with distinct anion selectivity. Cell Mol Life Sci 2012;69:2765–2778.

27. Conrad MP, Piontek J, Günzel D, Fromm M, Krug SM. Molecular basis of claudin-17 anion selectivity. Cell Mol Life Sci 2016;73:185–200.

28. Wen H, Watry DD, Marcondes MC, Fox HS. Selective decrease in paracellular conductance of tight junctions: role of the first extracellular domain of claudin-5. Mol Cell Biol 2004;24:8408–8417.

29. Yu AS, Enck AH, Lencer WI, Schneeberger EE. Claudin-8 expression in Madin-Darby canine kidney cells augments the paracellular barrier to cation permeation. J Biol Chem 2003;278:17350–17359.

30. Angelow S, Kim KJ, Yu AS. Claudin-8 modulates paracellular permeability to acidic and basic ions in MDCK II cells. J Physiol 2006;571(Pt 1):15–26.

31. Ben-Yosef T, Belyantseva IA, Saunders TL, et al. Claudin 14 knockout mice, a model for autosomal recessive deafness DFNB29, are deaf due to cochlear hair cell degeneration. Hum Mol Genet 2003;12:2049–2061.

32. Dimke H, Desai P, Borovac J, Lau A, Pan W, Alexander RT. Activation of the Ca(2+)-sensing receptor increases renal claudin-14 expression and urinary Ca(2+) excretion. Am J Physiol Renal Physiol 2013;304:F761–F769.

33. Jovov B, Van Itallie CM, Shaheen NJ, et al. Claudin-18: a dominant tight junction protein in Barrett’s esophagus and likely contributor to its acid resistance. Am J Physiol Gastrointest Liver Physiol 2007;293:G1106–G1113.

34. Angelow S, El-Husseini R, Kanzawa SA, Yu AS. Renal localization and function of the tight junction protein, claudin-19. Am J Physiol Renal Physiol 2007;293:F166–F177.

35. Sas D, Hu M, Moe OW, Baum M. Effect of claudins 6 and 9 on paracellular permeability in MDCK II cells. Am J Physiol Regul Integr Comp Physiol 2008;295:R1713–R1719.

36. Alexandre MD, Jeansonne BG, Renegar RH, Tatum R, Chen YH. The first extracellular domain of claudin-7 affects paracellular Cl- permeability. Biochem Biophys Res Commun 2007;357:87–91.

37. Alexandre MD, Lu Q, Chen YH. Overexpression of claudin-7 decreases the paracellular Cl- conductance and increases the paracellular Na+ conductance in LLC-PK1 cells. J Cell Sci 2005;118(Pt 12):2683–2693.

38. Hou J, Renigunta A, Konrad M, et al. Claudin-16 and claudin-19 interact and form a cation-selective tight junction complex. J Clin Invest 2008;118:619–628.

39. Inai T, Kobayashi J, Shibata Y. Claudin-1 contributes to the epithelial barrier function in MDCK cells. Eur J Cell Biol 1999;78:849–855.

40. McCarthy KM, Francis SA, McCormack JM, et al. Inducible expression of claudin-1-myc but not occludin-VSV-G results in aberrant tight junction strand formation in MDCK cells. J Cell Sci 2000;113 Pt 19:3387–3398.

41. Milatz S, Krug SM, Rosenthal R, et al. Claudin-3 acts as a sealing component of the tight junction for ions of either charge and uncharged solutes. Biochim Biophys Acta 2010;1798:2048–2057.

42. Rosenthal R, Milatz S, Krug SM, et al. Claudin-2, a component of the tight junction, forms a paracellular water channel. J Cell Sci 2010;123(Pt 11):1913–1921.

43. Gong Y, Sunq A, Roth RA, Hou J. Inducible expression of claudin-1 in glomerular podocytes generates aberrant tight junctions and proteinuria through slit diaphragm destabilization. J Am Soc Nephrol 2017;28:106–117.

44. Kong L, Wu H, Zhou W, et al. Sirtuin 1: a target for kidney diseases. Mol Med 2015;21:87–97.

45. Hasegawa K, Wakino S, Simic P, et al. Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes. Nat Med 2013;19:1496–1504.

46. Koda R, Zhao L, Yaoita E, et al. Novel expression of claudin-5 in glomerular podocytes. Cell Tissue Res 2011;343:637–648.

47. Zhao L, Yaoita E, Nameta M, et al. Claudin-6 localized in tight junctions of rat podocytes. Am J Physiol Regul Integr Comp Physiol 2008;294:R1856–R1862.

48. Fromm M, Piontek J, Rosenthal R, Günzel D, Krug SM. Tight junctions of the proximal tubule and their channel proteins. Pflugers Arch 2017;469:877–887.

49. Muto S, Hata M, Taniguchi J, et al. Claudin-2-deficient mice are defective in the leaky and cation-selective paracellular permeability properties of renal proximal tubules. Proc Natl Acad Sci U S A 2010;107:8011–8016.

50. Yu AS. Paracellular transport and energy utilization in the renal tubule. Curr Opin Nephrol Hypertens 2017;26:398–404.

51. Kim S, Kim GH. Roles of claudin-2, ZO-1 and occludin in leaky HK-2 cells. PLoS One 2017;12:e0189221.

52. Curry JN, Yu AS. Paracellular calcium transport in the proximal tubule and the formation of kidney stones. Am J Physiol Renal Physiol 2019;316:F966–F969.

53. Curry JN, Tokuda S, McAnulty P, Yu AS. Combinatorial expression of claudins in the proximal renal tubule and its functional consequences. Am J Physiol Renal Physiol 2020;318:F1138–F1146.

54. Pei L, Solis G, Nguyen MT, et al. Paracellular epithelial sodium transport maximizes energy efficiency in the kidney. J Clin Invest 2016;126:2509–2518.

55. Tanaka H, Tamura A, Suzuki K, Tsukita S. Site-specific distribution of claudin-based paracellular channels with roles in biological fluid flow and metabolism. Ann N Y Acad Sci 2017;1405:44–52.

56. Curry JN, Saurette M, Askari M, et al. Claudin-2 deficiency associates with hypercalciuria in mice and human kidney stone disease. J Clin Invest 2020;130:1948–1960.

57. Balkovetz DF, Chumley P, Amlal H. Downregulation of claudin-2 expression in renal epithelial cells by metabolic acidosis. Am J Physiol Renal Physiol 2009;297:F604–F611.

58. Olinger E, Houillier P, Devuyst O. Claudins: a tale of interactions in the thick ascending limb. Kidney Int 2018;93:535–537.

59. Plain A, Alexander RT. Claudins and nephrolithiasis. Curr Opin Nephrol Hypertens 2018;27:268–276.

60. Prot-Bertoye C, Houillier P. Claudins in renal physiology and pathology. Genes (Basel) 2020;11:290.

61. Moor MB, Bonny O. Ways of calcium reabsorption in the kidney. Am J Physiol Renal Physiol 2016;310:F1337–F1350.

62. Hou J. Claudins and mineral metabolism. Curr Opin Nephrol Hypertens 2016;25:308–313.

63. Gong Y, Hou J. Claudin-14 underlies Ca⁺⁺-sensing receptor-mediated Ca⁺⁺ metabolism via NFAT-microRNA-based mechanisms. J Am Soc Nephrol 2014;25:745–760.

64. Oh IH, Jo CH, Kim S, Jo S, Chung S, Kim GH. Thick ascending limb claudins are altered to increase calciuria and magnesiuria in metabolic acidosis. Am J Physiol Renal Physiol 2021;320:F418–F428.

65. Gong Y, Renigunta V, Himmerkus N, et al. Claudin-14 regulates renal Ca⁺⁺ transport in response to CaSR signalling via a novel microRNA pathway. EMBO J 2012;31:1999–2012.

66. Arcidiacono T, Simonini M, Lanzani C, et al. Claudin-14 gene polymorphisms and urine calcium excretion. Clin J Am Soc Nephrol 2018;13:1542–1549.

67. Meyers N, Nelson-Williams C, Malaga-Dieguez L, et al. Hypokalemia associated with a claudin 10 mutation: a case report. Am J Kidney Dis 2019;73:425–428.

68. Leiz J, Schmidt-Ott KM. Claudins in the renal collecting duct. Int J Mol Sci 2019;21:221.

69. Gong Y, Yu M, Yang J, et al. The Cap1-claudin-4 regulatory pathway is important for renal chloride reabsorption and blood pressure regulation. Proc Natl Acad Sci U S A 2014;111:E3766–E3774.

70. Gong Y, Wang J, Yang J, Gonzales E, Perez R, Hou J. KLHL3 regulates paracellular chloride transport in the kidney by ubiquitination of claudin-8. Proc Natl Acad Sci U S A 2015;112:4340–4345.

71. Fan J, Tatum R, Hoggard J, Chen YH. Claudin-7 modulates Cl- and Na+ homeostasis and WNK4 expression in renal collecting duct cells. Int J Mol Sci 2019;20:3798.

72. Tatum R, Zhang Y, Salleng K, et al. Renal salt wasting and chronic dehydration in claudin-7-deficient mice. Am J Physiol Renal Physiol 2010;298:F24–F34.

73. Jo CH, Kim S, Oh IH, Park JS, Kim GH. Alteration of tight junction protein expression in Dahl salt-sensitive rat kidney. Kidney Blood Press Res 2017;42:951–960.

74. Stahl RA, Kanz L, Maier B, Schollmeyer P. Hyperchloremic metabolic acidosis with high serum potassium in renal transplant recipients: a cyclosporine A associated side effect. Clin Nephrol 1986;25:245–248.

75. Lee CH, Kim S, Kang CM, Kim WY, Kim J, Kim GH. Altered expression of tight junction proteins in cyclosporine nephrotoxicity. Am J Nephrol 2011;33:7–16.

76. Sassi A, Wang Y, Chassot A, et al. Interaction between epithelial sodium channel γ-subunit and claudin-8 modulates paracellular sodium permeability in renal collecting duct. J Am Soc Nephrol 2020;31:1009–1023.

77. Bleich M, Günzel D. Physiology, pathophysiology, and clinical impact of claudins. Pflugers Arch 2017;469:1–2.